Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation
Enrico Maffini(Istituto di Ematologia di Bologna), Mohamad Mohty(Sorbonne Université), Maria Losa Maroto(NIHR Surgical Reconstruction and Microbiology Research Centre), Igor-Wolfgang Blau(Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie), Fabio Ciceri(Vita-Salute San Raffaele University), Cristina Castilla‐Llorente(Institut Gustave Roussy), Ibrahim Yakoub‐Agha(Inserm), Maud Ngoya, Arnon Nagler(Sheba Medical Center), Khalid Halahleh(King Hussein Cancer Center), Radovan Vrḫovac(University Hospital Centre Zagreb), Malek Benakli(University of Algiers Benyoucef Benkhedda), Emma Nicholson(Royal Marsden Hospital), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Mohamed Houhou(Sorbonne Université), Matthias Eder(Medizinische Hochschule Hannover), Péter Reményi(Budapest University of Economics and Business), Babak Bahar(Shariati Hospital), Henrik Sengeloev(Rigshospitalet), Andrew Clark(Queen Elizabeth University Hospital), Catherine Flynn, Regis Peffault de Latour(Assistance Publique – Hôpitaux de Paris), Urpu Salmenniemi, Jakob Passweg(University Hospital of Basel), Etienne Daguindau(Hôpital Privé Jean Mermo), Alexandros Spyridonidis(General University Hospital of Patras)
Cited by 0
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k